The Current Ratio as of December 2025 (TTM) for Ascelia Pharma AB (publ) (ACE.ST) is 3.60

According to Ascelia Pharma AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 3.60. This represents a change of 77.64% compared to the average of 2.03 of the last 4 quarters.

Ascelia Pharma AB (publ) (ACE.ST) Historical Current Ratio (quarterly & annually)

How has ACE.ST Current Ratio performed in the past?

The mean historical Current Ratio of Ascelia Pharma AB (publ) over the last ten years is 9.62. The current 3.60 Current Ratio has changed 3.64% with respect to the historical average. Over the past ten years (40 quarters), ACE.ST's Current Ratio was at its highest in in the March 2019 quarter at 23.69. The Current Ratio was at its lowest in in the September 2017 quarter at 0.

Ascelia Pharma AB (publ) (ACE.ST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Ascelia Pharma AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ascelia Pharma AB (publ) (ACE.ST) Average Current Ratio

How has ACE.ST Current Ratio performed in the past?

The current Current Ratio of Ascelia Pharma AB (publ) (ACE.ST) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Ascelia Pharma AB (publ) (ACE.ST) Current Ratio vs. Peers

How is ACE.ST’s Current Ratio compared to its peers?

Ascelia Pharma AB (publ)’s Current Ratio is greater than Mendus AB (publ) (2.47), less than Intervacc AB (publ) (11.00), greater than Magle Chemoswed Holding AB (publ) (1.96), greater than Xintela AB (publ) (0.23), less than Moberg Pharma AB (publ) (16.14), less than Karolinska Development AB (publ) (7.99), less than Elicera Therapeutics AB (publ) (3.76), less than Isofol Medical AB (publ) (6.80), greater than Lipum AB (publ) (0.62), greater than IRLAB Therapeutics AB (publ) (1.30),

Build a custom stock screener for Ascelia Pharma AB (publ) (ACE.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ascelia Pharma AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ascelia Pharma AB (publ) (ACE.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ascelia Pharma AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.